Cbz-QFR-kbt
Cbz-QFR-kbt is a ketone-based benzothiazole ketone inhibitor of TMPRSS2, with an IC50 value of 0.42 nM. Cbz-QFR-kbt also has inhibitory activity against Matriptase, Hepsin, HGFA, and Factor Xa, with IC50 values of 1, 1.3, 85, and 85 nM respectively. Cbz-QFR-kbt shows significant inhibitory effects against SARS-CoV-2 and H1N1 (IC50 = 60 nM) . Cbz-QFR-kbt can be used in antiviral research[1].
Product Specifications
CAS Number
3086979-57-6
UNSPSC
12352005
Target
Factor Xa; Influenza Virus; SARS-CoV; Ser/Thr Protease
Related Pathways
Anti-infection; Metabolic Enzyme/Protease
Field of Research
Infection
Smiles
NC(NCCC[C@@H](C(C1=NC(C=CC=C2)=C2S1)=O)NC([C@H](CC3=CC=CC=C3)NC([C@H](CCC(N)=O)NC(OCC4=CC=CC=C4)=O)=O)=O)=N
Molecular Formula
C35H40N8O6S
Molecular Weight
700.81
References & Citations
[1]Banas V, et al. Inhibitors of membrane associated serine proteases block replication of coronavirus SARS-CoV-2 and influenza virus H1N1. Eur J Med Chem. 2026 Jan 15;302 (Pt 3) :118385.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
NBP2-70688G 0.1 mL
Mouse Monoclonal ER alpha/NR3A1 Antibody (OTI2D3) [DyLight 488]
Sign In for Pricing
View Details MBS1317463-01 0.02 mg (E-Coli)
Recombinant Pongo abelii Microtubule-associated protein RP/EB family member 2 (MAPRE2)
Sign In for Pricing
View Details